Bank Of New York Mellon Corp Burning Rock Biotech LTD Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$9.43 - $17.14 $341,120 - $620,022	-36,174 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $14,938 - $24,011	860 Added 2.44%	36,174 $647,000
Q2 2021 Aug 11, 2021	BUY	$26.14 - $37.45 $923,107 - $1.32 Million	35,314 New	35,314 $1.04 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $684M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.